Related Experiment Video
Updated: Jun 28, 2026

Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells
Published on: June 16, 2019
Effects of Survivin on cell proliferation and apoptosis in MG-63 cells in vitro
Xinjun Liang1, Mingxu Da, Zhiqiang Zhuang
1Department of Orthopaedics, Sun-Yat-Sen Memorial Hospital, Sun-Yat-Sen University, 107 West Yanjiang Road, Guangzhou 510120, PR China.
Abstract:
Osteosarcoma is the most frequent primary malignant tumor of the skeleton and occurs mainly in children and adolescent. The prognosis of osteosarcoma is very poor due to its aggressive and no effective treatment. This study is the first to investigate the anti-cancer effects of antisense pEGFP-C1-Survivin on human osteosarcoma cells. It was shown in our results that Survivin blockaded could significantly induce apoptosis and inhibit the invasive of osteosarcoma cells line MG-63. The effects were probably produced by the decreased expression of Survivin induced by antisense pEGFP-C1-Survivin which was examined by RT-PCR and western blotting. All these suggested that Survivin should be very important in the development of osteosarcoma and Survivin blockaded by using antisense pEGFP-C1-Survivin could markedly inhibit the proliferation and invasion of osteosarcoma cells line MG-63, partially reversed their malignant phenotype. Targeting Survivin might be a promising option in the treatment of osteosarcoma.
Insights
This study shows that blocking Survivin with antisense pEGFP-C1-Survivin can kill osteosarcoma cells and stop their spread. This suggests targeting Survivin may be a new way to treat this aggressive bone cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Osteosarcoma is a primary bone cancer with poor prognosis, especially in children and adolescents.
- Current treatments for osteosarcoma are limited, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the anti-cancer effects of antisense pEGFP-C1-Survivin on human osteosarcoma cells.
- To evaluate the potential of targeting Survivin as a therapeutic approach for osteosarcoma.
Main Methods:
- Utilized antisense pEGFP-C1-Survivin to inhibit Survivin expression in MG-63 osteosarcoma cells.
- Assessed apoptosis induction and invasive potential using cell-based assays.
- Confirmed Survivin downregulation via Reverse Transcription Polymerase Chain Reaction (RT-PCR) and Western blotting.
Main Results:
- Survivin blockade significantly induced apoptosis in osteosarcoma cells.
- Inhibition of Survivin markedly reduced the invasive capabilities of osteosarcoma cells.
- Downregulation of Survivin expression was confirmed at both mRNA and protein levels.
Conclusions:
- Survivin plays a critical role in the development and progression of osteosarcoma.
- Antisense pEGFP-C1-Survivin effectively inhibits osteosarcoma cell proliferation and invasion, partially reversing malignant phenotypes.
- Targeting Survivin represents a promising therapeutic strategy for osteosarcoma treatment.
Related Concept Videos
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
The Intrinsic Apoptotic Pathway

